Bailard »

Oramed Pharm shares owned by Bailard

Quarter-by-quarter ownership of Oramed Pharm (ORMP) shares owned by Bailard from 13F filings

Historical chart of Bailard investment in Oramed Pharm

Tip: Access up to 7 years of quarterly data

All positions including Oramed Pharm held by Bailard consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oramed Pharm by Bailard

Quarter filed Position value Share count Share price at filing
2026-03-31 $110k 33k 3.40

More positions owned by Bailard

Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Alphabet Cap Stk Cl A (GOOGL)
Spdr Gold Tr Gold Shs (GLD)
Ishares Tr Msci Eafe Etf (EFA)
Gilead Sciences (GILD)
Spdr Series Trust State Street Spd (BIL)
Vanguard World Inf Tech Etf (VGT)
J P Morgan Exchange Traded F Mortgage Backed (JMTG)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Calif Mun Bd Etf (CMF)
Vanguard Index Fds Total Stk Mkt (VTI)
Amazon (AMZN)

View all positions for Bailard

Top funds holding Oramed Pharm

BML Capital Management
Aquamarine Financial
Mercer Global Advisors
SB Capital Management
Murchinson
Boothbay Fund Management
Marshall Wace
Rathbones Brothers
Dimensional Fund Advisors
Wells Fargo & Company
Comprehensive Portfolio Management
Renaissance Technologies
Bank of America Corporation
O'shaughnessy Asset Management
Citadel Advisors

View all funds holding Oramed Pharm